One of the most widely
prescribed drugs in the
management of diabetes type 2,
metformin, has been shown in
a study in the American Journal
of Physiology to improve portal
hypertension in cirrhotic animals
after one week of treatment.
Although only demonstrated in
rats at this stage the study opens
the way for human studies.
The strongest effect was evident
when metformin was added to a
standard antihypertensive, betablocker
propranalol, when portal
hypertension in cirrhotic rats was
reduced by more than 27%.
The combination could become
a new approach to treating portal
hypertension in patients with
cirrhosis, the authors concluded.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jul 15
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.